This factor suppresses ovarian cancer cell growth and proliferation in vitro [151], reduces expression of pathogenic APA-induced androgen receptor variant, and up-regulates expression of the full-length androgen receptor in prostate cancer cells [359]. Here, AR is linked to ovarian carcinoma.